![](https://i0.wp.com/newcambridgeobserver.com/wp-content/uploads/2018/06/Bob-Langer.jpg?fit=150%2C150&ssl=1?v=1673527805)
Writer Anita Harris interviews biotech pioneer Robert Langer of MIT on how researchers can avoid the dreaded “valley of death” and start successful companies (as he has).
Cambridge-Paris Ariana Pharma reports that it has joined the WIN Consortium as an official technology partner. The Consortium (Worldwide Innovative Networking in personalized cancer medicine) is a global collaboration of 40 leading organizations whose aim is to develop more effective cancer diagnostics and therapeutics, shorten clinical trial timelines and reduce the overall cost of cancer care.